JP2021521154A5 - - Google Patents
Info
- Publication number
- JP2021521154A5 JP2021521154A5 JP2020555350A JP2020555350A JP2021521154A5 JP 2021521154 A5 JP2021521154 A5 JP 2021521154A5 JP 2020555350 A JP2020555350 A JP 2020555350A JP 2020555350 A JP2020555350 A JP 2020555350A JP 2021521154 A5 JP2021521154 A5 JP 2021521154A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- methoxy
- salt
- methoxypropoxy
- contacting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862656605P | 2018-04-12 | 2018-04-12 | |
| US62/656,605 | 2018-04-12 | ||
| US201862700048P | 2018-07-18 | 2018-07-18 | |
| US62/700,048 | 2018-07-18 | ||
| PCT/US2019/027004 WO2019200109A1 (en) | 2018-04-12 | 2019-04-11 | Methods for preparing substituted pyridinone-containing tricyclic compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021521154A JP2021521154A (ja) | 2021-08-26 |
| JP2021521154A5 true JP2021521154A5 (enExample) | 2022-03-25 |
Family
ID=68163316
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020555350A Pending JP2021521154A (ja) | 2018-04-12 | 2019-04-11 | 置換ピリジノン含有三環式化合物を調製するための方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11505551B2 (enExample) |
| EP (1) | EP3773584A4 (enExample) |
| JP (1) | JP2021521154A (enExample) |
| KR (1) | KR20200142529A (enExample) |
| CN (1) | CN112839654A (enExample) |
| AU (1) | AU2019252441A1 (enExample) |
| CA (1) | CA3096687A1 (enExample) |
| TW (1) | TW202010499A (enExample) |
| WO (1) | WO2019200109A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12128044B2 (en) | 2018-08-28 | 2024-10-29 | Sunshine Lake Pharma Co., Ltd. | Fused tricyclic compounds and uses thereof in medicine |
| JP2022511378A (ja) | 2018-09-30 | 2022-01-31 | サンシャイン・レイク・ファーマ・カンパニー・リミテッド | 縮合四環系化合物および医薬品におけるそれらの使用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR78491B (enExample) | 1982-03-24 | 1984-09-27 | Nat Res Dev | |
| JPS60197684A (ja) | 1984-03-21 | 1985-10-07 | Dainippon Pharmaceut Co Ltd | ベンゾ〔ａ〕キノリジン誘導体およびその塩 |
| ITFI970193A1 (it) | 1997-08-01 | 1999-02-01 | Applied Research Systems | Uso di derivati benzo(c) chinolizinici come regolatori della crescita delle piante e composizioni ad uso agricolo che contengono tali |
| TWI232863B (en) | 2001-06-11 | 2005-05-21 | Akzo Nobel Nv | Benzoxazepine derivatives |
| US8063037B2 (en) | 2007-05-07 | 2011-11-22 | N. V. Organon | Progesterone receptor modulators |
| US8835461B2 (en) * | 2009-03-26 | 2014-09-16 | Shionogi & Co., Ltd. | Substituted 3-hydroxy-4-pyridone derivative |
| PE20160686A1 (es) * | 2014-01-30 | 2016-07-23 | Hoffmann La Roche | Nuevas dihidroquinolizinonas para el tratamiento y profilaxis de la infeccion por virus de la hepatitis b |
| CN106459032B (zh) | 2014-05-13 | 2019-04-05 | 豪夫迈·罗氏有限公司 | 治疗和预防乙型肝炎病毒感染的新的二氢喹嗪酮类 |
| US10415037B2 (en) | 2014-10-02 | 2019-09-17 | Arbutus Biopharma Corporation | Compositions and methods for silencing hepatitis B virus gene expression |
| US9637485B2 (en) | 2014-11-03 | 2017-05-02 | Hoffmann-La Roche Inc. | 6,7-dihydrobenzo[a]quinolizin-2-one derivatives for the treatment and prophylaxis of hepatitis B virus infection |
| EP3325477B1 (en) | 2015-07-21 | 2019-05-01 | H. Hoffnabb-La Roche Ag | Novel tricyclic 4-pyridone-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis b virus infection |
| WO2017016960A1 (en) * | 2015-07-24 | 2017-02-02 | F. Hoffmann-La Roche Ag | Process for the preparation of (6s)-6-alkyl-10-alkoxy-9-(substituted alkoxy)-2-oxo-6,7-dihydrobenzo[a]quinolizine-3-carboxylic acid analogues |
| CN109071447B (zh) | 2016-02-19 | 2022-04-22 | 诺华股份有限公司 | 四环吡啶酮化合物作为抗病毒剂 |
| WO2017216685A1 (en) | 2016-06-16 | 2017-12-21 | Novartis Ag | Pentacyclic pyridone compounds as antivirals |
| WO2017216686A1 (en) | 2016-06-16 | 2017-12-21 | Novartis Ag | 8,9-fused 2-oxo-6,7-dihydropyrido-isoquinoline compounds as antivirals |
| WO2018019297A1 (zh) | 2016-07-29 | 2018-02-01 | 银杏树药业(苏州)有限公司 | 异喹啉酮类化合物及其制备抗病毒药物的应用 |
| CA3031063A1 (en) | 2016-07-29 | 2018-02-01 | Newave Pharmaceutical Inc. | Benzo-quinolizin-2oxo carboxylic acid derivatives for the treatment of hbv infection |
| CN107759585A (zh) | 2016-07-29 | 2018-03-06 | 银杏树药业(苏州)有限公司 | 一种异喹啉类化合物及其药用组合物和作为抗病毒药物的应用 |
| TW201811788A (zh) | 2016-09-09 | 2018-04-01 | 瑞士商諾華公司 | 作為抗病毒劑之多環吡啶酮化合物 |
| JP7113009B2 (ja) | 2016-11-07 | 2022-08-04 | アービュタス バイオファーマ コーポレイション | 置換ピリジノン含有三環式化合物およびそれを使用する方法 |
| CN106810548B (zh) | 2017-01-13 | 2019-02-15 | 苏州爱科百发生物医药技术有限公司 | 一种二氢异喹啉类化合物 |
-
2019
- 2019-04-11 TW TW108112756A patent/TW202010499A/zh unknown
- 2019-04-11 US US17/046,139 patent/US11505551B2/en active Active
- 2019-04-11 AU AU2019252441A patent/AU2019252441A1/en not_active Abandoned
- 2019-04-11 JP JP2020555350A patent/JP2021521154A/ja active Pending
- 2019-04-11 KR KR1020207031646A patent/KR20200142529A/ko not_active Ceased
- 2019-04-11 CN CN201980037491.8A patent/CN112839654A/zh active Pending
- 2019-04-11 WO PCT/US2019/027004 patent/WO2019200109A1/en not_active Ceased
- 2019-04-11 EP EP19784904.5A patent/EP3773584A4/en not_active Withdrawn
- 2019-04-11 CA CA3096687A patent/CA3096687A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6926329B2 (ja) | ６−（２−ヒドロキシ−２−メチルプロポキシ）−４−（６−（６−（（６−メトキシピリジン−３−イル）メチル）−３，６−ジアザビシクロ［３．１．１］ヘプタン−３−イル）ピリジン−３−イル）ピラゾロ［１，５−ａ］ピリジン−３−カルボニトリルの調製のためのプロセス | |
| Song et al. | Organometallic methods for the synthesis and functionalization of azaindoles | |
| AU2006265019B2 (en) | Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compounds | |
| AU2019403149B2 (en) | Substituted heterocycle fused gamma-carbolines synthesis | |
| US5739145A (en) | Antitussive agents | |
| JP2020520946A5 (enExample) | ||
| HRP20050159A2 (en) | Preparation of 1h-imidazo[4,5-c]quinolin-4-amines via 1h-imidazo [4,5-c]quinolin-4-ph-thalimide intermediates | |
| JP5738992B2 (ja) | プロパン−１−スルホン酸｛３−［５−（４−クロロ−フェニル）−１Ｈ−ピロロ［２，３−ｂ］ピリジン−３−カルボニル］−２，４−ジフルオロ−フェニル｝−アミドの新規製造方法 | |
| TWI690520B (zh) | 製備二芳基硫尿囊素化合物之方法 | |
| JP2019516708A5 (enExample) | ||
| JP2006505567A5 (enExample) | ||
| CN113845509B (zh) | 吲哚基取代螺[环丁烷-1，1′-茚]类化合物的合成方法 | |
| JP6839715B2 (ja) | １−（４−メタンスルホニル−２−トリフルオロメチル−ベンジル）−２−メチル−１Ｈ−ピロロ［２，３−ｂ］ピリジン−３−イル−酢酸を調製するための方法 | |
| CN115605460A (zh) | 杂环化合物的合成 | |
| CN101005840A (zh) | 制备喜树碱衍生物及其新中间体和化合物的方法 | |
| TW200836726A (en) | Pyrrolopyridine-2-carboxamide derivatives, preparation thereof and therapeutic use thereof | |
| ZA200601552B (en) | Imidazopyridine-derivatives as inducible no-synthase inhibitors | |
| TW202010499A (zh) | 經取代的吡啶酮之三環化合物的製備方法 | |
| JPH09507064A (ja) | ４−アリールイソインドール鎮痛薬 | |
| WO2001070747A1 (en) | Process for producing camptothecin | |
| CA2562812A1 (en) | Imidazopyridine compound | |
| CN112898331B (zh) | 一种2-硅杂茚满化合物及其合成方法 | |
| JP2005529112A (ja) | ジェミフロキサシン酸性塩類の製造方法 | |
| JP2015524846A5 (enExample) | ||
| JP3354526B2 (ja) | トロバフロキサシン酸塩の製造方法 |